| CNA | Copy number alterations |
| CPTAC | Clinical Proteomic Tumor Analysis Consortium |
| DDR | Damage response |
| DNA | Deoxyribonucleic acid |
| ER | Endoplasmic reticulum |
| FBS | Fetal Bovine Serum |
| HBEC | Human bronchial epithelial cells |
| H-Score | Histochemical Score |
| G3BP1 | GTPase-activating protein-binding protein 1 |
| G3BP2 | GTPase-activating protein-binding protein 2 |
| ICI | Immune checkpoint inhibitor |
| IHC | Immunohistochemistry |
| LUAD | Lung adenocarcinoma |
| LUSC | Lung squamous cell carcinoma |
| MMR | Mismatch Repair |
| mRNA | Messenger RNA |
| mRNP | Messenger ribonucleoproteins |
| NSCLC | Non-small cell lung cancer |
| OS | Overall survival |
| PFS | Progression-free survival |
| PSI | Percent splice in |
| RBP | RNA-binding protein |
| SCLC | Small cell lung cancer |
| SG | Stress granules |
| TCGA | The Cancer Genome Atlas |
| TIIC | Tumor-infiltrating immune cells |
| TNBC | Triple-negative breast cancer |
| TMA | Tissue microarray |
| TMB | Tumor mutational burden |